The world is a buzz with COVID-19 news and rightfully so. I want to cover hydroxychloroquine clinical pearls. This drug has been purported to have activity against coronavirus. Here’s a link to that research article. Uses of Hydroxychloroquine While it is...
I’m seeing this article all over the place recommending to avoid NSAIDs in patients who have an infection with the new COVID-19 coronavirus. My question is, where’s the evidence? The only thing I can find is that it was based upon is a scientific theory as...
FDA Approval The FDA has recently approved two generic versions of apixaban and from the amount of apixaban I’m seeing used in clinical practice, this is a great thing for overall healthcare and drug costs. Here’s the FDA’s statement. Because of this...
OTC Tamiflu may be a reality in the near future. Sanofi has purchased the over-the-counter rights for Tamiflu and is pursuing approval from the FDA. I do have some potential concerns with this medication becoming an over-the-counter option. For the pharmacology,...
In an update from a previous post, the CPJE cheating scandal rolls on. Over 1,000 pharmacy students had their scores invalidated. This means that they have to make plans to retake the CPJE exam. In their most recent update on the CPJE cheating scandal, the California...
The author has no conflicts of interest regarding oral semaglutide or any other diabetes medication. The GLP-1 agonists have been growing in popularity. The benefit of good A1C lowering effect coupled with the potential for weight loss are two of the main reasons why...
